A potent inhibitor of dipeptidyl peptidase IV (DPP IV), an enzyme that cleaves glucagon-like peptide 1 (GLP-1). Delaying the degradation of GLP-1 extends the action of insulin and suppressing the release of glucagon which results in reduction in elevated blood glucose levels (hyperglycemia)....
Know who made it. See the evidence. Buy through one marketplace.
A potent inhibitor of dipeptidyl peptidase IV (DPP IV), an enzyme that cleaves glucagon-like peptide 1 (GLP-1). Delaying the degradation of GLP-1 extends the action of insulin and suppressing the release of glucagon which results in reduction in elevated blood glucose levels (hyperglycemia). Clinically useful antidiabetic agent. Ameliorates cognitive deficits in streptozotocin-induced Alzheimers disease model. Displays protective effects on β-cells by inhibition of ER stress in a mouse model
This product is manufactured by TriBio Science and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
DPP4 identifies dipeptidyl peptidase 4 in Homo sapiens (Human). This target record connects NCBI Gene 1803, UniProtKB P27487 and related ABMIUM catalogue products.
Biological function: Dipeptidyl peptidase 4 (DPP4; CD26/DPP IV) is a type II transmembrane serine peptidase that removes N-terminal dipeptides from susceptible peptides and also functions as a cell-surface signalling and costimulatory protein. It is studied in incretin metabolism, glucose homeostasis and immune regulation.
